INTERLEUKIN-2 REQUIREMENT FOR THE INVITRO GENERATION OF ANTITUMOR CYTO-TOXICITY BY THYMOCYTES FROM MELPHALAN-CURED MOPC-315 TUMOR BEARERS

被引：0

作者：

MOKYR, MB

BARTIK, MM

AHN, MC

机构：

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：870 / 876

页数：7

共 39 条

[1] AUGMENTATION OF DELAYED-TYPE HYPERSENSITIVITY BY DOSES OF CYCLOPHOSPHAMIDE WHICH DO NOT AFFECT ANTIBODY-RESPONSES
ASKENASE, PW
HAYDEN, BJ
GERSHON, RK
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1975, 141 (03) : 697 - 702
[2] BALLAS ZK, 1987, J IMMUNOL, V139, P3542
[3] BARKER E, 1988, CANCER RES, V48, P4834
[4] BARTIK MM, 1987, CANCER RES, V47, P4848
[5] BENEFRAIM S, 1983, CANCER IMMUNOL IMMUN, V15, P101
[6] BERD D, 1984, CANCER RES, V44, P1275
[7] BERD D, 1986, CANCER RES, V46, P2572
[8] BERD D, 1987, CANCER RES, V47, P3317
[9] ACTIVE IMMUNOTHERAPY OF HUMAN-MELANOMA EXPLOITING THE IMMUNOPOTENTIATING EFFECTS OF CYCLOPHOSPHAMIDE
BERD, D
MASTRANGELO, MJ
[J]. CANCER INVESTIGATION, 1988, 6 (03) : 337 - 349
[10] BOCIAN RC, 1984, CANCER IMMUNOL IMMUN, V18, P41